Saturday 17 October 2026
Export VCYT’s income statement to Excel — free account
Veracyte, Inc.
VCYT Healthcare Diagnostics & Research
Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.5%, EPS grew 3,300.0% and free cash flow grew 33.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
43.12
1.27
−2.86%
Follow VCYT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
8 | 8 | 8 | 8 |
| 2.49% | 5.34% | 6.93% | 8.77% | ||
| 2.29% | 4.90% | 6.40% | 8.09% | ||
ROIC |
1.74% | 4.03% | 5.35% | 7.32% | |
Return on Tangible Assets |
7.66% | 14.72% | 18.01% | 21.44% | |
Average Days of Receivables |
35.26 | 31.52 | 33.76 | 35.19 | |
Free Cash Flow per Share |
1.25 | 1.61 | 1.95 | 2.08 | |
Free Cash Flow |
98.21 | 126.63 | 155.34 | 165.99 | |
Capital Expenditures |
(10.04) | (9.68) | (10.82) | (12.39) | |
| Other line items | |||||
Cash ROIC |
6.05% | 7.35% | 8.71% | 8.86% | |
Accounts Receivable Turnover |
10.25 | 11.34 | 10.43 | 10.70 | |
Accounts Payable Turnover |
20.53 | 23.38 | 13.93 | 16.33 | |
Inventory Turnover |
7.66 | 7.31 | 6.90 | 6.67 | |
Average Days of Payables |
12.90 | 10.84 | 16.00 | 18.43 | |
Days of Inventory on Hand |
47.61 | 48.50 | 49.61 | 52.03 | |
Tax Rate |
(0.02) | (0.03) | (0.03) | (0.01) | |
Research and Development Expense of Revenue |
13.99% | 13.69% | 14.80% | 16.62% | |
Selling, General and Administrative Expense of Revenue |
44.31% | 40.79% | 37.57% | 35.88% | |
Share Based Compensation of Revenue |
8.55% | 8.43% | 8.38% | 8.63% | |
Operating CF/Net income |
3.57 | 2.05 | 1.89 | 1.56 | |
Depreciation/Fixed assets |
1.03 | 0.82 | 0.82 | 0.83 | |
Capex/Depreciation |
(0.52) | (0.53) | (0.59) | (0.68) | |
Revenue per Share |
6.29 | 6.58 | 6.81 | 7.03 | |
Operating CF per Share |
1.38 | 1.73 | 2.09 | 2.23 | |
Capex per Share |
(0.13) | (0.12) | (0.14) | (0.15) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates